The compound selectively reduces mPGES-1 activity, differentiating it from current endometriosis therapies like celecoxib and NSAIDs, which act further upstream in the prostaglandin pathway, reducing the activity of all prostaglandin synthases
If vials are at room temperature but exposure was less than 48 hours, refrigerate at 2-8C and reconstitute within 7 days
To avoid this, its essential to rotate injection sites regularly, such as alternating between thighs or using different areas within the same muscle
doi:10.3389/fendo.2024.1431292 Lv D, Feng P, Guan X, et al
Baldrich P, Rutter BD, Karimi HZ, Podicheti R, Meyers BC, Innes RW
KLOW is a precision-engineered peptide blend containing: GHK-Cu (50 mg) KPV (10 mg) BPC-157 (10 mg) TB500 (10 mg) Each peptide targets a distinct but complementary biological pathway